Pharmaceutical

KKM-191-D by Genuone Science for Type 2 Diabetes: Likelihood of Approval

KKM-191-D is under clinical development by Genuone Science and is currently in the Phase I in clinical pathway.

Aug 10, 2023 - 20:00
KKM-191-D is under clinical development by Genuone Science and is currently in the Phase I in clinical pathway.
Read the original article

Tags:

Previous Article

JY-302 by Jin Yang Pharmaceutical for Type 2 Diabetes: Likelihood of Approval

Next Article

CD70 CAR-T by UTC Therapeutics for Marginal Zone B-cell Lymphoma: Likelihood of ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Viatris gets grant for nasal spray method for treating ...

Apr 25, 2024

Opinion: Listen: Physicians have a moral and professional obligation to get into ‘good trouble’

Opinion: Listen: Physicians have a moral and profession...

Jun 14, 2023

STAT+: More hospital pharmacists are rationing drugs due to increasing shortages

STAT+: More hospital pharmacists are rationing drugs du...

Aug 11, 2023